Skip to main content

Generics

  • Creating generic powerhouses

    A deal announced last month between CVS Caremark and Cardinal Health created a joint venture that the companies said would be the largest generic drug sourcing entity in the United States.

    Each company will have a 50% stake in the joint venture, contributing its respective sourcing and supply chain expertise. The deal also included an extension of Cardinal Health’s existing pharmaceutical distribution agreement with CVS Caremark through June 2019.

  • Mylan hires Adele Gulfo to head global collaboration, strategic operations

    PITTSBURGH — Generic drug maker Mylan has hired a former Pfizer executive to its executive leadership team.

    The company announced Wednesday the appointment of Adele Gulf as EVP global collaboration and strategic operations. Before working for Mylan, Gulfo served as regional president of Latin America for Pfizer's Emerging Markets Business Unit, overseeing more than 4,000 employees in 23 countries and achieving more than $3 billion in sales in Latin America in 2012.

  • ECRM unveils ECRM Data, a turnkey solution for promotional tracking and analysis functions

    SOLON, Ohio — Efficient Collaborative Retail Marketing on Wednesday unveiled the ECRM Data web site, ECRMData.com. ECRM Data is an industry solution that offers turnkey solutions for promotional tracking and analysis functions.

  • Ani Pharmaceuticals buys 31 generic drugs from Teva with combined annual sales of $860 million

    BAUDETTE, Minn. — Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.

  • Big Y, En-Vision America partner on adherence tool for visually impaired

    SPRINGFIELD, Mass. — Big Y pharmacies and En-Vision America have recently partnered on a pair of novel programs designed to improve compliance among seniors with impaired vision. 

    "The pharmacists are engaging with all patients and making them aware of this new service," Jan Winn, Big Y director of pharmacy, HABC and GM, shared with DSN. "The larger print labels are a big hit with the 'babyboom' generation."

  • Publix extends Sync Your Refills program chainwide

    LAKELAND, Fla. — Publix on Tuesday announced plans to expand a new Sync Your Refills program to all pharmacies. After a successful test in the Atlanta Division, the program will expand companywide to the remaining Publix Pharmacies by Friday, Jan. 24. 

  • CMS report finds lower health spending growth in 2012; generic drugs touted as 'critical to cost control'

    WASHINGTON — Growth in health spending has slowed in recent years, including spending by private and public payers, according to data released Monday by the Centers for Medicare and Medicaid Services that also found a small contribution to the lower growth from the healthcare reform law.

  • Mylan launches generic version of Detrol LA

    PITTSBURGH — Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.

    Mylan announced the launch of tolterodine tartrate extended-release capsules in the 2-mg and 4-mg strengths. The drug is used to treat overactive bladder with symptoms of urinary incontinence, urgency and frequency.

    The drug is a generic version of Pfizer's Detrol LA. Tolterodine tartrate extended-release capsules had sales of about $571.5 million during the 12-month period that ended in September, according to IMS Health.

X
This ad will auto-close in 10 seconds